Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
06/2003
06/19/2003WO2003049680A2 Compositions containing both sedative and non-sedative antihistamines
06/19/2003WO2003049679A2 Mitotic kinesin inhibitors
06/19/2003WO2003049678A2 Mitotic kinesin inhibitors
06/19/2003WO2003049675A2 Treating muscle wasting with selective androgen receptor modulators
06/19/2003WO2003049673A2 Methods and compositions for control of bone formation via modulation of sympathetic tone
06/19/2003WO2003049593A2 Prevention of flap necrosis in plastic surgery
06/19/2003WO2003049527A2 Mitotic kinesin inhibitors
06/19/2003WO2003035002A3 Management of postoperative pain
06/19/2003WO2003020252A3 Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents
06/19/2003WO2003013438A3 Nutrient therapy for immuno-compromised patients
06/19/2003WO2003009777A3 Delivery of therapeutic capable agents
06/19/2003WO2002094864A3 Human cdnas and proteins and uses thereof
06/19/2003WO2002077237A3 Transporters and ion channels
06/19/2003WO2002060434A3 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
06/19/2003WO2002048172A3 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus
06/19/2003WO2002044342A9 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof
06/19/2003WO2002042462A3 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
06/19/2003WO2002034899A3 Tec kinase assay
06/19/2003WO2002008244A3 Peptides as ns3-serine protease inhibitors of hepatitis c virus
06/19/2003WO2002004514A3 Compositions and methods for the therapy and diagnosis of lung cancer
06/19/2003WO2001015676A9 Compositions and methods for modulating hdl cholesterol and triglyceride levels
06/19/2003US20030114678 Cardioprotective phosphonates and malonates
06/19/2003US20030114677 Cardioprotective phosphonates and malonates
06/19/2003US20030114658 Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use
06/19/2003US20030114526 Administration to a human for hair growth a formulation containing a compound selected from lupane triterpenes and derivatives, derivatives of oleanane triterpenes, derivatives of ursane derivatives or salts and mixtures; antialopecia
06/19/2003US20030114522 Topical anesthetic
06/19/2003US20030114507 Therapeutic treatment of virus infections; cell antigrowth agents; treating human herpes viruses
06/19/2003US20030114504 Compositions and methods for the treatment of cancer
06/19/2003US20030114499 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker
06/19/2003US20030114486 Novel quinolinones and uses thereof
06/19/2003US20030114484 Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
06/19/2003US20030114483 Synergistic mixture of chromene compound and acetaminophen
06/19/2003US20030114482 Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies
06/19/2003US20030114478 Asthma therapy; antiinflammatory agents
06/19/2003US20030114469 Combinations
06/19/2003US20030114464 Synergistic mixture containing quinolone antibiotic such as floxacin; also fungicide; topical applying to eye
06/19/2003US20030114460 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics
06/19/2003US20030114459 Synergistic mixture with prostaglandins; analgesics
06/19/2003US20030114444 Analgesics
06/19/2003US20030114443 Viricides, Aids therapy
06/19/2003US20030114440 Compositions and methods of treatment for conditions responsive to testosterone elevation
06/19/2003US20030114420 Anticancer agents, autoimmunine diseases, congestive heart failure, skin disorders, antiinflammatory agents
06/19/2003US20030114418 Analgesics; antiinflammatory and arthritic agents; osteoarthritis; rheumatic diseases; gastrointestinal, nervous system, respiratory disorders; wound healing agents; vision defects; kits
06/19/2003US20030114416 Analgesics; antiinflammatory, -arthritic agents; vision defects; gastrointestinal and uorgenital disorders; wound healing agents; kits
06/19/2003US20030114394 Vaginally administered anti-dysrhythmic agents for treating pelvic pain
06/19/2003US20030114392 Process for preparing pseudoephedrine tannate
06/19/2003US20030114391 A therapeutic antihistamine, sustained release, a salt formation of carbinoxamine with tannins
06/19/2003US20030114390 Treating diabetic with a sodium dependent glucose transporters (SGLT2) inhibitors, especially type II diabetes
06/19/2003US20030114384 Methods and compositions for treating lesions of the respiratory epithelium
06/19/2003US20030114382 Angiogenesis inhibition
06/19/2003US20030114365 Neurotrophic pipecolic acid derivative compounds having an affinity for FKBP-type immunophilins; treating neurodegenrative disorders
06/19/2003US20030114357 Antidiabetic agents
06/19/2003US20030114355 Arthroscopic irrigation solution and method for inhibition of pain and inflammation
06/19/2003US20030113873 Screening modulators of G-protein coupled binding proteins; analgesics; muscle-relaxants; cognition activators; learning enhancement
06/19/2003US20030113870 Polypeptides homologous to VEGF and BMP1
06/19/2003US20030113844 Delayed rectifier potassium channel subunit
06/19/2003US20030113812 Evaluating modulators of neuron propagation; bone morphogenetic proteins; epidermal growth factors; erythropoietins; pleiotrophins; hepatocyte growth factors; somatomedins; nerve growth factors; interleukins
06/19/2003US20030113808 Apolipoprotein biopolymer markers predictive of alzheimers disease
06/19/2003US20030113803 Orphan receptor
06/19/2003US20030113789 Protease peptides; anticarcinogenic agents; neurotransmitters; antidiabetic agents
06/19/2003US20030113772 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113771 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113764 Compositions and methods for the treatment of tumors
06/19/2003US20030113393 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
06/19/2003US20030113392 Proteoglycan compositions for treating arthritic inflammatory conduitions
06/19/2003US20030113389 Wherein dose of jojoba product provides simmondsin component in an amount greater than 0.05 gram/day
06/19/2003US20030113386 For countering or slowing down appearance of signs of ageing of skin
06/19/2003US20030113385 Use of combinations of active agents consisting of antimicrobially active substances and plant extracts containing terpene in veterinary medicine
06/19/2003US20030113382 Causing cyclic GMP to increase in the neoplastic cells and exposing neoplastic cells to cisplatin derivative
06/19/2003US20030113381 Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
06/19/2003US20030113375 Pharmaceutical formulation and process
06/19/2003US20030113366 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
06/19/2003US20030113359 Prosthetic device placed on the outside surface of the vessel or graft which then elutes antiproliferatives from a matrix
06/19/2003US20030113333 A kit containing a binding protein and a carrier molecule, binds with a hapten moiety and binds with a target antigen; monoclonal antibodies and engineered antibodies
06/19/2003US20030113331 An antagonist specifically binds to a denatured collagens; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists
06/19/2003US20030113323 High mobility group proteins; diagnostic monitoring the severity or potential lethality of sepsis or septic shock, measuring the serum protein concentration of patient, treating weight loss or obesity
06/19/2003US20030113303 Delivering a translocation stimulator to a target zone of the tissue, introducing human embryonic stem cells to the mammal for homing the human to the target zone of the tissue for effecting myogenesis at the target zone
06/19/2003US20030113295 Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders
06/19/2003US20030113290 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; nitric oxide synthase modulators; hypotensive agents
06/19/2003US20030113278 Treatment of excessive radiation (e.g. sunburn) exposure
06/19/2003CA2655959A1 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
06/19/2003CA2470104A1 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
06/19/2003CA2469893A1 Phenylalkynes
06/19/2003CA2469889A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003CA2469679A1 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
06/19/2003CA2469670A1 Quinazoline derivatives for the treatment of abnormal cell growth
06/19/2003CA2469616A1 Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
06/19/2003CA2469607A1 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003CA2469595A1 Treatment of glioblastoma with thymosin-alpha 1
06/19/2003CA2469340A1 Treating muscle wasting with selective androgen receptor modulators
06/19/2003CA2469316A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003CA2469306A1 Methods and compositions for control of bone formation via modulation of sympathetic tone
06/19/2003CA2469204A1 Prospective identification and characterization of breast cancer stem cells
06/19/2003CA2469161A1 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
06/19/2003CA2469000A1 Method for reducing acne or improving skin tone
06/19/2003CA2468994A1 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
06/19/2003CA2468989A1 Treatment for age-related macular degeneration
06/19/2003CA2468794A1 Treatment of neoplasia
06/19/2003CA2468792A1 Glucosamine organic acid adducts
06/19/2003CA2468749A1 Use of an h1 antagonist and a safe steroid to treat rhinitis
1 ... 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 ... 1151